An Expanded Access Protocol to Administer Decitabine to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome.
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2009
At a glance
- Drugs Decitabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Adverse reactions
- Sponsors Eisai Inc; MGI Pharma
- 11 Oct 2008 New trial record.